Electromed, Inc. (ELMD): R&D Expense
$1.31M
Year ended 2026-06-30
+12.8%
3-year compound annual growth
-5.3%
5-year compound annual growth
+13.2%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $1.31M | +31.9% | 2026-08-25, From 2025-07-01 |
| 2025-06-30 | $996.0K | +51.8% | 2026-08-25, From 2024-07-01 |
| 2024-06-30 | $656.0K | -28.4% | 2025-08-26, From 2023-07-01 |
| 2023-06-30 | $916.0K | -32.4% | 2024-08-27, From 2022-07-01 |
| 2022-06-30 | $1.36M | -21.3% | 2023-08-22, From 2021-07-01 |
| 2021-06-30 | $1.72M | +64.0% | 2022-08-23, From 2020-07-01 |
| 2020-06-30 | $1.05M | +80.0% | 2021-08-24, From 2019-07-01 |
| 2019-06-30 | $583.3K | +132.0% | 2020-08-25, From 2018-07-01 |
| 2018-06-30 | $251.4K | -57.9% | 2019-08-27, From 2017-07-01 |
| 2017-06-30 | $596.9K | +56.9% | 2018-09-25, From 2016-07-01 |
| 2016-06-30 | $380.4K | +20.5% | 2017-09-05, From 2015-07-01 |
| 2015-06-30 | $315.6K | -32.3% | 2016-09-06, From 2014-07-01 |
| 2014-06-30 | $466.1K | -22.8% | 2015-09-15, From 2013-07-01 |
| 2013-06-30 | $603.4K | -34.5% | 2014-09-23, From 2012-07-01 |
| 2012-06-30 | $920.8K | -10.9% | 2013-09-25, From 2011-07-01 |
| 2011-06-30 | $1.03M | n/a | 2012-09-26, From 2010-07-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Electromed, Inc. (ELMD) | 2026-06-30 | $1.31M | +31.9% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $19.14M | +41.2% |
| Vaso Corp (VASO) | 2025-12-31 | $728.0K | -14.5% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $7.57M | +59.3% |
| Iridex Corp (IRIX) | 2026-01-03 | $3.67M | -32.7% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $21.23M | -44.7% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $9.38M | -3.9% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $32.88M | +18.4% |
| Precision Optics Corporation, Inc. (POCI) | 2025-06-30 | $1.16M | +17.9% |
Compare ELMD, CBLL, VASO, BLFS side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗